A development stage company was a formal accounting classification under U.S. GAAP for a business still in its pre-revenue phase — raising capital, building a product, and not yet earning meaningful money from planned operations. The Financial Accounting Standards Board eliminated the classification in 2014, so the label itself no longer carries any reporting requirements.1Financial Accounting Standards Board. FASB Issues Standard to Improve Financial Reporting for Development Stage Entities Pre-revenue companies still exist in large numbers, of course, and they face a distinct set of disclosure, going concern, and tax rules that have simply moved to other parts of the codification and the tax code.
What the Classification Used to Require
Before 2014, FASB’s Accounting Standards Codification Topic 915 set out who qualified and what they had to report. A company met the definition when it devoted substantially all of its efforts to establishing a new business and either had not yet begun its planned principal operations or had begun them but produced no significant revenue.1Financial Accounting Standards Board. FASB Issues Standard to Improve Financial Reporting for Development Stage Entities The definition captured newly formed startups along with older organizations that had pivoted into a new line of business and were not yet earning from it.
Topic 915 then layered on extra disclosures. A qualifying entity had to present inception-to-date figures in its income statement, cash flow statement, and statement of shareholders’ equity, label its financial statements as those of a development stage entity, and describe the activities it was engaged in. When the company finally exited the stage, it had to disclose that fact in its first post-transition filing.2PwC. Development Stage Entities (Topic 915) The logic was that period-to-period comparisons mean little when there is no revenue history, so cumulative data since inception gave investors something concrete to measure.
Why FASB Eliminated It
In June 2014, FASB issued Accounting Standards Update No. 2014-10 and removed Topic 915 from the codification. The update eliminated all incremental financial reporting requirements for development stage entities, including the inception-to-date disclosures and the labeling requirement.3Financial Accounting Standards Board. FASB In Focus – Development Stage Entities (Topic 915) The changes took effect for public companies in reporting periods beginning after December 15, 2014, and for private entities in annual periods beginning after that same date.
FASB’s reasoning came down to a cost-benefit judgment. Stakeholders told the board that the “development stage entity” label stigmatized companies and made capital-raising harder, without producing information that standard disclosures couldn’t already provide. The inception-to-date data was expensive to compile and rarely used by analysts in a way that justified the effort. The same update also amended the variable interest entity guidance in ASC Topic 810 to remove a provision that had used development stage status as a factor in consolidation analysis.4IAS Plus. FASB Eliminates DSE Concept From U.S. GAAP
A pre-revenue startup filing financial statements today follows the same GAAP rules as an established company. No special label, no mandatory cumulative data, no separate reporting framework for being early-stage. The scrutiny moved rather than disappeared.
What a Pre-Revenue Company Discloses Today
Even without Topic 915, pre-revenue companies face meaningful disclosure obligations. FASB clarified that the requirements in ASC Topic 275, covering risks and uncertainties, apply to entities that have not commenced planned principal operations.4IAS Plus. FASB Eliminates DSE Concept From U.S. GAAP Under Topic 275, a company must describe the nature of its operations, discuss significant estimates used in its financial statements, and disclose vulnerabilities stemming from concentrations, whether in revenue sources, suppliers, or geographic markets.
For a pre-revenue company, Topic 275 effectively forces much of the same transparency Topic 915 once mandated, just through a different route. A startup with no revenue, heavy cash burn, and dependence on a single funding source has to disclose each of those facts as a risk and uncertainty. The footnotes do most of the work, describing the company’s plan of operations, how it intends to fund itself, and what milestones it needs to hit before becoming self-sustaining.
Going Concern
The most consequential disclosure for any pre-revenue company is whether it can survive the next twelve months. Under ASC 205-40, management must evaluate going concern each annual and interim reporting period, looking forward one year from the date the financial statements are issued. If conditions suggest the company probably cannot meet its obligations as they come due within that window, substantial doubt exists and must be disclosed.
When substantial doubt is identified, management has to lay out its plans to address the problem: securing additional funding, cutting expenses, restructuring debt, or some combination. If those plans alleviate the doubt, the company still discloses that doubt existed initially, along with the conditions that triggered it and the plans that resolved it. If the plans do not alleviate it, the company must include an explicit statement that substantial doubt about its ability to continue as a going concern exists. Auditors apply a parallel standard under PCAOB Auditing Standard 2415 and add an explanatory paragraph to the audit report when doubt persists after considering management’s plans.5Public Company Accounting Oversight Board. Consideration of an Entity’s Ability to Continue as a Going Concern (AS 2415) For a company burning cash with no established revenue stream, this assessment happens virtually every reporting period and is often the single most important paragraph in the financials.
The Classification That Replaced It in Practice: Emerging Growth Company
For pre-revenue companies going public today, the classification that actually matters is Emerging Growth Company status, created by the JOBS Act in 2012. EGC status provides scaled disclosure and compliance accommodations designed to make the IPO process less burdensome for smaller companies.
A company qualifies as an EGC if it has total annual gross revenues below $1.235 billion during its most recently completed fiscal year. The status lasts for five fiscal years after the company completes its IPO, unless it hits one of the off-ramps earlier: crossing the revenue threshold, issuing more than $1 billion in non-convertible debt over a three-year period, or becoming a large accelerated filer.6U.S. Securities and Exchange Commission. Emerging Growth Companies
The practical benefits are significant. EGCs can submit draft registration statements confidentially for SEC review before going public. They can provide two years of audited financial statements in an IPO filing instead of three, and an EGC filing a registration statement prior to its IPO may omit historical financial information that it reasonably believes will not be required at the time of the actual offering.7U.S. Securities and Exchange Commission. Form S-1 Registration Statement Under the Securities Act of 1933 They are exempt from the Sarbanes-Oxley requirement for an external audit of internal controls and can adopt new accounting standards on the private company timeline rather than the public company one.
A separate category, the Smaller Reporting Company, offers additional scaled disclosure for public companies with a public float below $250 million, or those with less than $100 million in annual revenue and either no public float or a public float under $700 million.8U.S. Securities and Exchange Commission. Smaller Reporting Company Definition Many pre-revenue companies going public qualify under both and stack the benefits.
How R&D Spending Shows Up in the Financials
Research and development dominates the income statement of a pre-revenue company, and the accounting treatment is straightforward. Under ASC 730, all R&D costs are recognized as an expense when incurred. Personnel costs, contract research services, and indirect costs related to R&D are all expensed immediately. Materials, equipment, and facilities acquired specifically for R&D with no alternative future use get the same treatment.
The one exception involves R&D assets that have an alternative future use beyond the current research project. Equipment or facilities that could be repurposed for production or other activities can be capitalized and then depreciated over their useful lives, with the depreciation running through R&D expense as the assets are used. Intangible assets acquired in a business combination for use in R&D are also capitalized regardless of whether they have an alternative future use.
This immediate-expensing rule is why pre-revenue companies typically show large net losses even when they are executing on plan. The loss figure is largely a function of the accounting rule rather than a signal of operational failure.
Startup and R&D Costs on the Tax Return
Accounting treatment and tax treatment of early-stage spending are not the same thing, and conflating them is one of the more common mistakes founders make. For tax purposes, startup spending is governed by Section 195 of the Internal Revenue Code.
A company that begins active operations can elect to deduct up to $5,000 of qualifying startup expenditures in its first year. That $5,000 allowance phases out dollar-for-dollar once total startup costs exceed $50,000, disappearing entirely at $55,000. Any startup costs not deducted in the first year must be amortized ratably over 180 months, starting with the month the business begins operations.9eCFR. 26 CFR 1.195-1 – Election to Amortize Start-Up Expenditures Organizational costs follow an identical structure, with a separate $5,000 deduction, the same $50,000 phase-out, and 180-month amortization for the excess.
There is a critical catch. If a company incurs startup costs but never begins active operations, none of those costs are deductible. The Section 195 election only works once the business actually launches, so a company that spends two years in development and then folds never gets the tax benefit of that spending.
Research and experimental expenditures follow their own path. For tax years beginning after December 31, 2024, new Section 174A allows taxpayers to immediately deduct domestic R&E expenditures. Companies can alternatively elect to capitalize and amortize domestic R&E costs over at least 60 months.10Grant Thornton. Permanent Full Expensing for U.S. Research in OBBBA Research conducted outside the United States does not get this treatment and must still be capitalized and amortized over 15 years. Companies with offshore development teams need to plan around that distinction carefully.